Between 2000 and 2020, an estimated 482,000 primates were imported into the U.S. to be experimented on in testing laboratories. All the while, pharmaceutical drug development has been mired in serious challenges, particularly during the animal-heavy research stages known as preclinical phases. Now, a series of supply chain disruptions have created a shortage of primates for laboratory testing use.
This post was originally published on Latest – Truthout.